Home Ladder Bio

Ladder Bio

In operation
Seed Round Financing
Developer of Targeted Drug Discovery Platforms

Basic Information

Ladder Bio is a therapeutic company developing Helical Oligomer™ ladder-like peptide molecules — sequence-defined, structurally pre-organized molecules designed for oral administration, cell permeability, and high-affinity, selective binding to challenging biological targets. Ladder Bio’s platform combines rational design with modern discovery to create new therapeutic options for patients underserved by traditional approaches.
Ladder Bio Inc.
Pennsylvania,United States of America
15~50 people
January 01, 2020
info@ladderbio.com